Phospholipase A-2-activating protein
Phospholipase A-2-activating protein is an enzyme that in humans is encoded by the PLAA gene.[1][2][3]
References
- ↑ Chopra AK, Ribardo DA, Wood TG, Prusak DJ, Xu XJ, Peterson JW (Mar 1999). “Molecular characterization of cDNA for phospholipase A2-activating protein”. Biochim Biophys Acta. 1444 (1): 125–30. doi:10.1016/s0167-4781(98)00249-8. PMID 9931468.
- ↑ Beatty BG, Qi S, Pienkowska M, Herbrick JA, Scheidl T, Zhang ZM, Kola I, Scherer SW, Seth A (Mar 2000). “Chromosomal localization of phospholipase A2 activating protein, an Ets2 target gene, to 9p21”. Genomics. 62 (3): 529–32. doi:10.1006/geno.1999.5999. PMID 10644453.
- ↑ “Entrez Gene: PLAA phospholipase A2-activating protein”.
Further reading
- Clark MA, Ozgür LE, Conway TM, et al. (1991). “Cloning of a phospholipase A2-activating protein”. Proc. Natl. Acad. Sci. U.S.A. 88 (12): 5418–22. doi:10.1073/pnas.88.12.5418. PMC 51884. PMID 2052621.
- Maruyama K, Sugano S (1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Ruiz A, Nadal M, Puig S, Estivill X (1999). “Cloning of the human phospholipase A2 activating protein (hPLAP) gene on the chromosome 9p21 melanoma deleted region”. Gene. 239 (1): 155–61. doi:10.1016/S0378-1119(99)00354-6. PMID 10571045.
- Seigneurin-Berny D, Verdel A, Curtet S, et al. (2001). “Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways”. Mol. Cell. Biol. 21 (23): 8035–44. doi:10.1128/MCB.21.23.8035-8044.2001. PMC 99970. PMID 11689694.
- Kozlenkov A, Manes T, Hoylaerts MF, Millán JL (2002). “Function assignment to conserved residues in mammalian alkaline phosphatases”. J. Biol. Chem. 277 (25): 22992–9. doi:10.1074/jbc.M202298200. PMID 11937510.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Koumanov K, Momchilova A, Wolf C (2004). “Bimodal regulatory effect of melittin and phospholipase A2-activating protein on human type II secretory phospholipase A2”. Cell Biol. Int. 27 (10): 871–7. doi:10.1016/S1065-6995(03)00176-8. PMID 14499668.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Humphray SJ, Oliver K, Hunt AR, et al. (2004). “DNA sequence and analysis of human chromosome 9”. Nature. 429 (6990): 369–74. doi:10.1038/nature02465. PMC 2734081. PMID 15164053.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Rual JF, Venkatesan K, Hao T, et al. (2005). “Towards a proteome-scale map of the human protein-protein interaction network”. Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH